F M Investments LLC Sells 128,262 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

F M Investments LLC cut its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 63.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 74,329 shares of the company's stock after selling 128,262 shares during the quarter. F M Investments LLC owned about 0.13% of Astrana Health worth $2,344,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in ASTH. Janus Henderson Group PLC purchased a new position in shares of Astrana Health during the third quarter worth approximately $1,164,000. Principal Financial Group Inc. purchased a new stake in shares of Astrana Health in the third quarter valued at approximately $13,383,000. Franklin Resources Inc. purchased a new position in Astrana Health in the third quarter worth approximately $1,187,000. Geode Capital Management LLC purchased a new stake in Astrana Health in the third quarter valued at approximately $58,995,000. Finally, State Street Corp acquired a new stake in Astrana Health during the 3rd quarter worth approximately $91,966,000. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Trading Down 1.6 %

Shares of ASTH stock traded down $0.55 during mid-day trading on Wednesday, reaching $33.21. 93,421 shares of the stock traded hands, compared to its average volume of 271,497. The stock's fifty day simple moving average is $32.31 and its two-hundred day simple moving average is $39.72. Astrana Health, Inc. has a 1-year low of $23.12 and a 1-year high of $63.20. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The company has a market cap of $1.66 billion, a price-to-earnings ratio of 25.55, a price-to-earnings-growth ratio of 1.37 and a beta of 1.04.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company had revenue of $665.21 million for the quarter, compared to the consensus estimate of $617.24 million. On average, research analysts anticipate that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ASTH has been the subject of several research reports. Bank of America reduced their target price on Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a report on Tuesday, March 4th. Barclays started coverage on Astrana Health in a report on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 target price on the stock. Stifel Nicolaus reduced their price target on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a report on Thursday, February 20th. Robert W. Baird lowered their target price on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. Finally, Truist Financial cut their price objective on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a report on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Astrana Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.